Olfr845, also known as OrX, represents a member of the olfactory receptor family, particularly in Mus musculus (house mouse). In the intricate realm of the olfactory system, Olfr845 plays a pivotal role as a sensory gatekeeper, allowing mice to perceive and interact with their environment through scent recognition. This member of the olfactory receptor family is akin to a molecular sentinel, stationed in the nasal epithelium, awaiting its crucial duty: the recognition of odorant molecules. As with other olfactory receptors, Olfr845 follows the common structural blueprint of G-protein-coupled receptors (GPCRs), boasting a seven-transmembrane domain structure that is fundamental for its functional prowess. The primary function of Olfr845 revolves around its extraordinary ability to interact with odorant molecules present in the environment. When an odorant molecule finds its way to Olfr845's binding site, a complex cascade of intracellular events is set into motion. This initiation leads to the activation of downstream signaling pathways, facilitating the transmission of signals that culminate in the perception of specific odors. The olfactory receptor gene family in mice, to which Olfr845 belongs, constitutes one of the most extensive gene families within the genome. It's noteworthy that the nomenclature assigned to olfactory receptor genes and proteins in mice is independent of their counterparts in other organisms.
Inhibition of Olfr845's function represents a multifaceted challenge, primarily because specific direct inhibitors for this receptor are not readily available. Therefore, indirect inhibition strategies emerge as potential avenues for altering Olfr845 activity. These indirect approaches often involve the modulation of cellular pathways and processes that are intertwined with Olfr845's function. For instance, targeting the PI3K/AKT pathway with inhibitors can lead to indirect Olfr845 inhibition by disrupting AKT phosphorylation, which plays a role in olfactory signal transduction. Similarly, compounds that impact the p38 MAPK pathway can indirectly influence Olfr845 by altering downstream signaling events related to olfaction. Additionally, the inhibition of the ERK/MAPK pathway can potentially suppress Olfr845 expression by blocking ERK phosphorylation, affecting its role in signal transduction. In conclusion, Olfr845 represents a critical player in the olfactory system of Mus musculus, functioning as a molecular sentinel that enables the perception of diverse odors. Its structural and functional characteristics align with those of other olfactory receptors, allowing it to fulfill its sensory role effectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences the SIRT1 pathway, potentially indirectly affecting Olfr845. It activates SIRT1, which may modulate downstream signaling cascades related to olfaction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 targets the PI3K/AKT pathway, which could indirectly impact Olfr845 expression by inhibiting AKT phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 affects the p38 MAPK pathway, potentially influencing Olfr845 through downstream signaling alterations. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits the ERK/MAPK pathway, which may indirectly suppress Olfr845 expression by blocking ERK phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin targets PI3K, potentially affecting Olfr845 by modulating the PI3K/AKT pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could indirectly lead to reduced Olfr845 expression through the mTOR signaling pathway. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences the NF-κB pathway, potentially affecting Olfr845 by reducing NF-κB activity and its downstream effects. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide targets Wnt/β-catenin signaling, which may indirectly impact Olfr845 by modulating the Wnt pathway. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
JSH-23 targets the NF-κB pathway, which could indirectly affect Olfr845 by reducing NF-κB activity and its downstream effects. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 modulates the TGF-β pathway, potentially impacting Olfr845 expression through downstream signaling alterations. | ||||||